Yi‐Kan Cheng

528 total citations
18 papers, 398 citations indexed

About

Yi‐Kan Cheng is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Yi‐Kan Cheng has authored 18 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in Yi‐Kan Cheng's work include Genetic factors in colorectal cancer (6 papers), Colorectal Cancer Surgical Treatments (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Yi‐Kan Cheng is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), Colorectal Cancer Surgical Treatments (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Yi‐Kan Cheng collaborates with scholars based in China and United States. Yi‐Kan Cheng's co-authors include Shubiao Ye, Ping Lan, Peisi Li, Yanhong Deng, Ru Deng, Runqing Huang, Huashan Liu, Jianwei Zhang, Xianrui Wu and Lizhi Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Yi‐Kan Cheng

18 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Kan Cheng China 9 243 182 126 52 46 18 398
Dillip Kumar Muduly India 8 181 0.7× 103 0.6× 112 0.9× 21 0.4× 57 1.2× 47 328
Tianliang Xia China 12 241 1.0× 125 0.7× 119 0.9× 23 0.4× 22 0.5× 21 366
Hong-Jae Jo South Korea 7 147 0.6× 90 0.5× 101 0.8× 42 0.8× 58 1.3× 11 273
Jinying Jia China 9 180 0.7× 181 1.0× 171 1.4× 37 0.7× 36 0.8× 13 382
Jugao Fang China 11 201 0.8× 105 0.6× 64 0.5× 15 0.3× 34 0.7× 30 313
Huanlei Wu China 10 201 0.8× 124 0.7× 80 0.6× 12 0.2× 16 0.3× 15 319
Jing Jin China 11 110 0.5× 214 1.2× 119 0.9× 79 1.5× 65 1.4× 39 352
Shunfang Yang China 4 222 0.9× 105 0.6× 85 0.7× 49 0.9× 51 1.1× 9 341
Huxiang Zhang China 9 151 0.6× 105 0.6× 64 0.5× 14 0.3× 21 0.5× 21 232

Countries citing papers authored by Yi‐Kan Cheng

Since Specialization
Citations

This map shows the geographic impact of Yi‐Kan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Kan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Kan Cheng more than expected).

Fields of papers citing papers by Yi‐Kan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Kan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Kan Cheng. The network helps show where Yi‐Kan Cheng may publish in the future.

Co-authorship network of co-authors of Yi‐Kan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Kan Cheng. A scholar is included among the top collaborators of Yi‐Kan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Kan Cheng. Yi‐Kan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cheng, Yi‐Kan, et al.. (2025). Tumor-intrinsic TTLL12 drives resistance to cancer immunotherapy via modulating myeloid-derived suppressor cells. Journal for ImmunoTherapy of Cancer. 13(6). e010873–e010873. 1 indexed citations
2.
Li, Peisi, Yi‐Kan Cheng, Yuan Chen, et al.. (2023). Tumor-secreted IFI35 promotes proliferation and cytotoxic activity of CD8+ T cells through PI3K/AKT/mTOR signaling pathway in colorectal cancer. Journal of Biomedical Science. 30(1). 47–47. 25 indexed citations
3.
Ye, Shubiao, Yi‐Kan Cheng, Peisi Li, et al.. (2023). High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer. npj Precision Oncology. 7(1). 50–50. 11 indexed citations
4.
5.
Cheng, Yi‐Kan, Ping Chen, Xiaosheng He, et al.. (2022). Association of Peripheral Blood Biomarkers With Response to Anti-PD-1 Immunotherapy for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer: A Multicenter Cohort Study. Frontiers in Immunology. 13. 809971–809971. 15 indexed citations
6.
Cheng, Yi‐Kan, et al.. (2022). Comparative Safety, Efficacy and Survival Outcome of Anti-PD-1 Immunotherapy in Colorectal Cancer Patients With vs Without Hepatitis B Virus Infection: A Multicenter Cohort Study. Clinical and Translational Gastroenterology. 13(5). e00475–e00475. 7 indexed citations
7.
Ye, Shubiao, Yi‐Kan Cheng, Jiancong Hu, Feng Gao, & Ping Lan. (2020). Development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer. Annals of Translational Medicine. 8(4). 96–96. 6 indexed citations
8.
9.
Ye, Shubiao, Yi‐Kan Cheng, Lin Zhang, et al.. (2020). Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer. npj Precision Oncology. 4(1). 26–26. 25 indexed citations
10.
Cheng, Yi‐Kan, Qiyuan Qin, Xiaoyan Huang, et al.. (2019). Effect of interval between preoperative radiotherapy and surgery on clinical outcome and radiation proctitis in rectal cancer from FOWARC trial. Cancer Medicine. 9(3). 912–919. 7 indexed citations
11.
12.
Ye, Shubiao, Yi‐Kan Cheng, Lin Zhang, et al.. (2019). Prognostic value of estrogen receptor-α and progesterone receptor in curatively resected colorectal cancer: a retrospective analysis with independent validations. BMC Cancer. 19(1). 933–933. 19 indexed citations
13.
Cai, Hongmin, Xiaolin Pang, Dong Dong, et al.. (2019). Molecular Decision Tree Algorithms Predict Individual Recurrence Pattern for Locally Advanced Nasopharyngeal Carcinoma. Journal of Cancer. 10(15). 3323–3332. 5 indexed citations
14.
Deng, Ru, Yi‐Kan Cheng, Shubiao Ye, et al.. (2019). <p>m<sup>6</sup>A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways</p>. OncoTargets and Therapy. Volume 12. 4391–4402. 135 indexed citations
15.
Wang, Yunlong, Weixing Feng, Lili Feng, et al.. (2019). Epidermal growth factor receptor stabilizes programmed death ligand 1 by glycosylation in colorectal cancer with microstatellite instability status. SHILAP Revista de lepidopterología. 2(1). 1–8. 4 indexed citations
16.
Sun, Peng, Cui Chen, Xinlin Chen, et al.. (2014). Proposal of a clinical typing system and generation of a prognostic model in patients with nasopharyngeal carcinoma from Southern China.. PubMed. 19(2). 474–83. 8 indexed citations
17.
Sun, Peng, Cui Chen, Yi‐Kan Cheng, et al.. (2013). Serologic biomarkers of Epstein–Barr virus correlate with TNM classification according to the seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma. European Archives of Oto-Rhino-Laryngology. 271(9). 2545–2554. 28 indexed citations
18.
Liu, Na, Ruixue Cui, Ying Sun, et al.. (2013). A four‐miRNA signature identified from genome‐wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma. International Journal of Cancer. 134(6). 1359–1368. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dillip Kumar Muduly Breakdown of academic impact, for papers by Tianliang Xia Breakdown of academic impact, for papers by Hong-Jae Jo Breakdown of academic impact, for papers by Jinying Jia Breakdown of academic impact, for papers by Jugao Fang Breakdown of academic impact, for papers by Huanlei Wu Breakdown of academic impact, for papers by Jing Jin Breakdown of academic impact, for papers by Shunfang Yang Breakdown of academic impact, for papers by Huxiang Zhang
Rankless by CCL
2026